E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research

Online Publishing Date:
17 / 01 / 2023

 


Is nucleic acid amplification test sufficient enough for reducing the diagnostic dilemma of cervical lymph node tuberculosis? A descriptive study in a tertiary care hospital

Sritanu Jana, Debasis Mukhopadhyay, Sunita Bagdi, Arindam De, Swapan Pathak.


Abstract
Background: Pulmonary tuberculosis (TB) is common clinical presentation in India, but, nowadays, extrapulmonary TB (EPTB) is also a clinical problem. At present, no single test is available for diagnosing EPTB which is rapid, cost-effective, and confirmatory. Many studies were done to diagnose and treat the pulmonary TB, though more efforts are needed for diagnosis of EPTB.

Aims and Objectives: The aim of this study is to find out any test or a series of tests that reduce the diagnostic dilemma of cervical lymph node TB.

Materials and Methods: A total of 170 patients with cervical lymphadenopathy were enrolled in the pathology department between July 1, 2021, and December 31, 2021. It was a descriptive study and of cross-sectional design. The Institutional Ethics Committee approval was received (No. BSMC/IEC/101 dt. January 15, 2021). Suspected malignancy cases were excluded from the study. Fine-needle aspiration (FNA) was done for all these patients and stained with Leishman-Geimsa, Papaniculaou, and Zeihl-Neelsen (ZN) stain. After FNA, all samples were sent for cartridge based nucleic acid amplification test.

Results: After FNA cytology, ZN stain was done and only 9.2% of acid–fast bacilli (AFB) positive cases were found. Granuloma was found in 27.6% of cases. After nucleic acid amplification test (NAAT) study, it was found that 36.8% patients were positive. Total number of lymph node considered to be positive for TB (NAAT positive and/or ZN stain positive and/or presence of granuloma) is 85 (52.1%). As per conventional method for diagnosis of lymph node TB (presence of granuloma and/or AFB positive in ZN stain), number of cases were 50 (30.7%). NAAT test was significantly more positive in respect of ZN staining but not significantly positive in respect of presence of granuloma.

Conclusion: For diagnosis of cervical lymph node TB, all three methods (NAAT, ZN stain, and Leishman-Giemsa stain) should be used simultaneously.

Key words: Cartridge-Based Nucleic Acid Amplification Test; Extrapulmonary Tuberculosis; Cervical Lymphadenopathy


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Sritanu Jana
Articles by Debasis Mukhopadhyay
Articles by Sunita Bagdi
Articles by Arindam De
Articles by Swapan Pathak
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Jana S, Mukhopadhyay D, Bagdi S, De A, Pathak S. Is nucleic acid amplification test sufficient enough for reducing the diagnostic dilemma of cervical lymph node tuberculosis? A descriptive study in a tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2023; 13(2023, Vol: 13, Issue: 8): 1634-1638. doi:10.5455/njppp.2023.13.12606202205012022


Web Style

Jana S, Mukhopadhyay D, Bagdi S, De A, Pathak S. Is nucleic acid amplification test sufficient enough for reducing the diagnostic dilemma of cervical lymph node tuberculosis? A descriptive study in a tertiary care hospital. https://www.njppp.com/?mno=103991 [Access: March 14, 2024]. doi:10.5455/njppp.2023.13.12606202205012022


AMA (American Medical Association) Style

Jana S, Mukhopadhyay D, Bagdi S, De A, Pathak S. Is nucleic acid amplification test sufficient enough for reducing the diagnostic dilemma of cervical lymph node tuberculosis? A descriptive study in a tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2023; 13(2023, Vol: 13, Issue: 8): 1634-1638. doi:10.5455/njppp.2023.13.12606202205012022



Vancouver/ICMJE Style

Jana S, Mukhopadhyay D, Bagdi S, De A, Pathak S. Is nucleic acid amplification test sufficient enough for reducing the diagnostic dilemma of cervical lymph node tuberculosis? A descriptive study in a tertiary care hospital. Natl J Physiol Pharm Pharmacol. (2023), [cited March 14, 2024]; 13(2023, Vol: 13, Issue: 8): 1634-1638. doi:10.5455/njppp.2023.13.12606202205012022



Harvard Style

Jana, S., Mukhopadhyay, . D., Bagdi, . S., De, . A. & Pathak, . S. (2023) Is nucleic acid amplification test sufficient enough for reducing the diagnostic dilemma of cervical lymph node tuberculosis? A descriptive study in a tertiary care hospital. Natl J Physiol Pharm Pharmacol, 13 (2023, Vol: 13, Issue: 8), 1634-1638. doi:10.5455/njppp.2023.13.12606202205012022



Turabian Style

Jana, Sritanu, Debasis Mukhopadhyay, Sunita Bagdi, Arindam De, and Swapan Pathak. 2023. Is nucleic acid amplification test sufficient enough for reducing the diagnostic dilemma of cervical lymph node tuberculosis? A descriptive study in a tertiary care hospital. National Journal of Physiology, Pharmacy and Pharmacology, 13 (2023, Vol: 13, Issue: 8), 1634-1638. doi:10.5455/njppp.2023.13.12606202205012022



Chicago Style

Jana, Sritanu, Debasis Mukhopadhyay, Sunita Bagdi, Arindam De, and Swapan Pathak. "Is nucleic acid amplification test sufficient enough for reducing the diagnostic dilemma of cervical lymph node tuberculosis? A descriptive study in a tertiary care hospital." National Journal of Physiology, Pharmacy and Pharmacology 13 (2023), 1634-1638. doi:10.5455/njppp.2023.13.12606202205012022



MLA (The Modern Language Association) Style

Jana, Sritanu, Debasis Mukhopadhyay, Sunita Bagdi, Arindam De, and Swapan Pathak. "Is nucleic acid amplification test sufficient enough for reducing the diagnostic dilemma of cervical lymph node tuberculosis? A descriptive study in a tertiary care hospital." National Journal of Physiology, Pharmacy and Pharmacology 13.2023, Vol: 13, Issue: 8 (2023), 1634-1638. Print. doi:10.5455/njppp.2023.13.12606202205012022



APA (American Psychological Association) Style

Jana, S., Mukhopadhyay, . D., Bagdi, . S., De, . A. & Pathak, . S. (2023) Is nucleic acid amplification test sufficient enough for reducing the diagnostic dilemma of cervical lymph node tuberculosis? A descriptive study in a tertiary care hospital. National Journal of Physiology, Pharmacy and Pharmacology, 13 (2023, Vol: 13, Issue: 8), 1634-1638. doi:10.5455/njppp.2023.13.12606202205012022